Establishment of a new human osteosarcoma cell line, UTOS-1: Cytogenetic characterization by array comparative genomic hybridization

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Yasuda, Taketoshi ^a   Kanamori, Masahiko ^a   Nogami, Shigeharu ^a   Hori, Takeshi ^a   Oya, Takeshi ^a   Suzuki, Kayo ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; PROTEIN MDM2; PRIMER DNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MATRIX; CASE REPORT; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME ANALYSIS; CHROMOSOME XQ; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; GENE LOCUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; XENOGRAFT; ADOLESCENT; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; GENETICS; METHODOLOGY; MOUSE MUTANT; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PHASE CONTRAST MICROSCOPY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADOLESCENT; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CYTOGENETIC ANALYSIS; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; MICROSCOPY, PHASE-CONTRAST; NEOPLASM TRANSPLANTATION; NUCLEIC ACID HYBRIDIZATION; OSTEOSARCOMA; POLYMERASE CHAIN REACTION;

EID: 63149148755     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-26     Document Type: Article

References (47)

1. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. PA Meyers R Gorlick G Heller E Casper J Lane AG Huvos JH Healey, J Clin Oncol 1998 16 2452 2458 9667263
2. Current treatment of high grade osteosarcoma of the extremity: review. G Bacci S Lari, J Chemother 2001 13 235 243 11450880
3. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. A Uchida A Myoui N Araki H Yoshikawa Y Shinto T Ueda, Cancer 1997 79 411 415 10.1002/(SICI)1097-0142(19970115)79:2<411::AID-CNCR26>3.0.CO;2-2 9010116
4. Characterization of a new human osteosarcoma cell line OHS-4. B Fournier PA Price, J Cell Biol 1991 114 577 583 1860886 10.1083/jcb.114.3.577
5. Establishment and characterization of cell lines derived from a human osteosarcoma. T Yamane, Clin Orthop 1985 199 261 271 3862491
6. Establishment and characterization of an osteoblastic clonal cell line from human mandibular osteosarcoma (HMOS-1). H Yoshikawa M Ohishi S Kohriki M Yoshiura Y Ohsaki, Oral Oncol 1997 33 163 168 10.1016/S0964-1955(96)00075-9 9307724
7. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. SB Rodan Y Imai MA Thiede G Wesolowski D Thompson Z Bar-Shavit S Shull K Mann GA Rodan, Cancer Res 1987 47 4961 4966 3040234
8. Cytogenetic findings in 35 osteosarcoma specimens and a review of the literature. AK Boehm JA Squire J Bayani M Nelson J Neff JA Bridge, Pediatr Pathol Mol Med 2000 19 359 376 10.1080/15227950050193623
9. Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping. T Ozaki T Neumann D Wai KL Schäfer F van Valen N Lindner C Scheel W Böcker W Winkelmann B Dockhorn-Dworniczak J Horst C Poremba, Cancer Genet Cytogenet 2003 140 145 152 10.1016/S0165-4608(02)00685-4 12645653
10. A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations. B Cherrier F Gouin MF Heymann JP Thiéry F Rédini D Heymann F Duteille, Tumor Biol 2005 26 121 130 10.1159/000086483
11. Effects of tumor cell-derived interleukin 1 alpha on invasiveness of metastatic clones of murine RCT sarcoma through endothelial cells. T Yasuda H Matsui M Kanamori K Yudoh K Ohmori M Aoki H Tsuji, Tumor Biol 1999 20 105 116 10.1159/000030053
12. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. J Carmichael WG DeGraff AF Gazdar, Cancer Res 1987 47 936 942 3802100
13. Isoenzyme of alkaline phosphatase in germinoma cells. O Koide S Iwai T Kanno S Kanda, Am J Clin Pathol 1988 89 611 616 3282427
14. Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis. J Nishio H Iwasaki M Ishiguro Y Ohjimi S Yo T Isayama M Naito M Kikuchi, Genes Chromosomes Cancer 2001 30 305 309 10.1002/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2-R 11170290
15. ISCN. An international system for human cytogenetic Nomenclature. LG Shaffer N Tommerup editors, Basel: S Karger 2005
16. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. A Kallioniemi OP Kallioniemi D Sudar D Rutovitz JW Gray F Waldman D Pinkel, Science 1992 258 818 821 10.1126/science.1359641 1359641
17. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. G Bilbe E Roberts M Birch DB Evans, Bone 1996 19 437 445 10.1016/S8756-3282(96)00254-2 8922641
18. Establishment, characterization and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72). N Rochet J Dubousset C Mazeau E Zanghellini MF Farges HS de Novion A Chompret B Delpech N Cattan M Frenay J Gioanni, Int J Cancer 1999 82 282 285 10.1002/(SICI)1097-0215(19990719)82: 2<282::AID-IJC20>3.0.CO;2-R 10389764
19. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. JA Bridge M Nelson E McComb MH McGuire H Rosenthal G Vergara GE Maale S Spanier JR Neff, Cancer Genet Cytogenet 1997 95 74 87 10.1016/S0165-4608(96)00306-8 9140456
20. Aberrations of chromosomes 1 and 17 in six human osteosarcoma cell lines using double-target fluorescence in situ hybridization. H Murata K Kusuzaki H Takeshita Y Hirasawa T Ashihara T Abe J Inazawa, Cancer Genet Cytogenet 1998 107 7 10 10.1016/S0165-4608(98)00072-7 9809027
21. Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis. M Wolf M Tarkkanen T Hulsebos ML Larramendy A Forus O Myklebost LA Aaltonen I Elomaa S Knuutila, Int J Cancer 1999 82 329 333 10.1002/(SICI)1097-0215(19990730)82:3<329::AID-IJC4>3.0.CO;2-1 10399948
22. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. AA Sandberg JA Bridge, Cancer Genet Cytogenet 2003 145 1 30 10.1016/S0165-4608(03)00105-5 12885459
23. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. M Overholtzer PH Rao R Favis XY Lu MB Elowitz F Barany M Ladanyi R Gorlick AJ Levine, Proc Natl Acad Sci USA 2003 100 11547 11552 12972634 10.1073/pnas.1934852100
24. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. M Tarkkanen R Karhu A Kallioniemi I Elomaa AH Kivioja J Nevalainen T Böhling E Karaharju E Hyytinen S Knuutila OP Kallioniemi, Cancer Res 1995 55 1334 1338 7882332
25. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. B Beheshti I Braude P Marrano P Thorner M Zielenska JA Squire, Neoplasia 2003 5 53 62 12659670
26. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. JR Pollack CM Perou AA Alizadeh MB Eisen A Pergamenschikov CF Williams SS Jeffrey D Botstein PO Brown, Nat Genet 1999 23 41 46 10.1038/14385 10471496
27. Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas. TJ Hulsebos EH Bijleveld NT Oskam A Westerveld S Leenstra PC Hogendoorn J Bras, Genes Chromosomes Cancer 1997 18 279 285 10.1002/(SICI)1098-2264(199704)18: 4<279::AID-GCC5>3.0.CO;2-Y 9087567
28. Comparative genomic hybridization of low-grade central osteosarcoma. M Tarkkanen T Böhling G Gamberi P Ragazzini MS Benassi A Kivioja P Kallio I Elomaa P Picci S Knuutila, Mod Pathol 1998 11 421 426 9619593
29. Online access to CGH data of DNA sequence copy number changes. S Knuutila K Autio Y Aalto, Am J Pathol 2000 157 689 10934171
30. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. A Padar UG Sathyanarayana M Suzuki R Maruyama JT Hsieh EP Frenkel JD Minna AF Gazdar, Clin Cancer Res 2003 9 4730 4734 14581343
31. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. J Yu WK Leung MP Ebert RW Leong PC Tse MW Chan AH Bai KF To P Malfertheiner JJ Sung, Br J Cancer 2003 88 1560 1565 10.1038/sj.bjc.6600940 12771922
32. Principles of Cdk regulation. DO Morgan, Nature 1995 374 131 134 10.1038/374131a0 7877684
33. The retinoblastoma protein and cell cycle control. RA Weinberg, Cell 1995 81 323 330 10.1016/0092-8674(95)90385-2 7736585
34. MDM2 gene amplification in metastatic osteosarcoma. M Ladanyi C Cha R Lewis SC Jhanwar AG Huvos JH Healey, Cancer Res 1993 53 16 18 8416741
35. Amplification of a gene encoding a p53-associated protein in human sarcomas. JD Oliner KW Kinzler PS Meltzer DL George B Vogelstein, Nature 1992 358 80 83 10.1038/358080a0 1614537
36. The polyproline region of p53 is required to activate apoptosis but not growth arrest. D Sakamuro P Sabbatini E White GC Prendergast, Oncogene 1997 15 887 898 10.1038/sj.onc.1201263 9285684
37. Regulation of p53 stability by Mdm2. MH Kubbutat SN Jones KH Vousden, Nature 1997 387 299 303 10.1038/387299a0 9153396
38. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. R Candau DM Scolnick P Darpino CY Ying TD Halazonetis SL Berger, Oncogene 1997 15 807 816 10.1038/sj.onc. 1201244 9266967
39. Chromosomal regions involved in the pathogenesis of osteosarcomas. C Stock L Kager FM Fink H Gadner PF Ambros, Genes Chromosomes Cancer 2000 28 329 336 10.1002/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F 10862039
40. Comparative genomic hybridization analysis identifies gains of 1p35-36 and chromosome 19 in osteosarcoma. M Zielenska J Bayani A Pandita S Toledo P Marrano J Andrade A Petrilli P Thorner P Sorensen JA Squire, Cancer Genet Cytogenet 2001 130 14 21 10.1016/S0165-4608(01)00461-7 11672768
41. Amplification of 17p11.2-p12, including PMP22, TOP3A, and MAPK7 in high-grade osteosarcoma. M van Dartel PW Cornelissen S Redeker M Tarkkanen S Knuutila PC Hogendoorn A Westerveld I Gomes J Bras TJ Hulsebos, Cancer Genet Cytogenet 2002 139 91 96 10.1016/S0165-4608(02)00627-1 12550767
42. Overexpression through amplification of genes in chromosome region 17p11.2-p12 in high-grade osteosarcoma. M van Dartel S Redeker J Bras M Kool TJ Hulsebos, Cancer Genet Cytogenet 2004 152 8 14 10.1016/j.cancergencyto.2003.09. 024 15193436
43. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. J Henriksen TH Aagesen GM Maelandsmo RA Lothe O Myklebost A Forus, Oncogene 2003 22 5358 5361 10.1038/sj.onc.1206671 12917637
44. Amplification and overexpression of genes in 17p11.2-p12 in osteosarcoma. M van Dartel TJ Hulsebos, Cancer Genet Cytogenet 2004 153 77 80 10.1016/j.cancergencyto.2004.03.007 15325100
45. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. JA Squire J Pei P Marrano B Beheshti J Bayani G Lim L Moldovan M Zielenska, Genes Chromosomes Cancer 2003 38 215 225 10.1002/gcc.10273 14506695
46. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. M Tarkkanen I Elomaa C Blomqvist AH Kivioja P Kellokumpu-Lehtinen T Böhling J Valle S Knuutila, Int J Cancer 1999 84 114 121 10.1002/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q 10096241
47. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. J Bayani M Zielenska A Pandita K Al-Romaih J Karaskova K Harrison JA Bridge P Sorensen P Thorner JA Squire, Genes Chromosomes Cancer 2003 36 7 16 10.1002/gcc.10132 12461745